Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells
Molecular Therapy - Methods and Clinical Development - United States
doi 10.1016/j.omtm.2017.03.005
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Elsevier BV